Sort
261,768 grants matching “gene therapy”
Models for Vision Research
$933,566Patsy M Nishina · Jackson Laboratory · R01 · FY2013 · EY
Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology
$933,533Li Xu · Revopsis Therapeutics, Inc. · R44 · FY2024 · EY
Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology
$933,533Li Xu · Revopsis Therapeutics, Inc. · R44 · FY2025 · EY
Resolving the cancer relevance of predisposition gene mutations
$933,468Fergus Joseph Couch · Mayo Clinic Rochester · R35 · FY2022 · CA
Trial Readiness and Endpoint Assessment in LGMDR1 (TREATing-LGMDR1)
$933,443Nicholas Elwood Johnson · Virginia Commonwealth University · U01 · FY2025 · NS
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIV
$933,381Michael Jay Corley · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · MH
Effects of Abscisic Acid on Insulin Sensitivity
$933,303Raquel Hontecillas · Biotherapeutics, Inc. · R44 · FY2020 · DK
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
$933,288Haian Fu · Emory University · U01 · FY2018 · CA
National Gene Vector Biorepository and Coordinating Center at Indiana University
$933,175Lilith Reeves · Indiana University Indianapolis · P40 · FY2014 · HL
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$933,101Xihong Lin · Harvard School Of Public Health · R35 · FY2020 · CA
Alveolus as Incubator: Functional Genomic Dissection of the Host Response to SARS-CoV-2 Infection.
$933,000Anthony W Orvedahl · Washington University · DP2 · FY2024 · AI
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$933,000Kory J. Lavine · Washington University · R35 · FY2025 · HL
The Development of a Web-based Data Retrieval System for HIV Therapy Guidance
$932,999Christos J Petropoulos · Monogram Biosciences, Inc. · R44 · FY2008 · AI
Epidemiology of the four most frequent cancers following breast cancer
$932,958Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
NOVEL THERAPEUTIC STRATEGIES IN LEUKEMIA AND LYMPHOMA
$932,947Dana-Farber Cancer Institute · P01 · FY2001 · CA
Mouse Models of FXTAS: Defining Critical Periods and Molecular Targets
$932,813Robert F Berman · University Of California At Davis · RL1 · FY2009 · NS
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer
$932,751Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2023 · CA
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer
$932,751Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2024 · CA
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
$932,722Haian Fu · Emory University · U01 · FY2020 · CA
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
$932,694Anne E Chiaramello · George Washington University · UH3 · FY2024 · TR
Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy
$932,613Debra Kimless · Pure Green Pharmaceuticals, Inc. · R44 · FY2024 · DK
Complex Neurodegenerative Disorders Clinic
$932,612Justin Kwan · National Institute Of Neurological Disorders And Stroke · ZID · FY2023 · NS
Molecular Pathogenesis of Acute Myeloid Leukemia
$932,549Timothy J Ley · Washington University · R35 · FY2025 · CA
Development of an inhibitory oligonucleotide for the treatment of lupus
$932,510Robert L Coffman · Dynavax Technologies Corporation · R44 · FY2009 · AI
Walking Forward - American Indian Participation in Cancer Clinical Trials
$932,394Daniel G Petereit · Rapid City Regional Hospital · U54 · FY2011 · CA